KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Current Leases (2019 - 2026)

Bio-Rad Laboratories has reported Current Leases over the past 8 years, most recently at $36.2 million for Q1 2026.

  • Quarterly Current Leases fell 12.35% to $36.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $36.2 million through Mar 2026, down 12.35% year-over-year, with the annual reading at $36.1 million for FY2025, 13.43% down from the prior year.
  • Current Leases was $36.2 million for Q1 2026 at Bio-Rad Laboratories, roughly flat from $36.1 million in the prior quarter.
  • Over five years, Current Leases peaked at $42.8 million in Q3 2024 and troughed at $34.0 million in Q3 2022.
  • The 5-year median for Current Leases is $36.8 million (2025), against an average of $38.3 million.
  • Year-over-year, Current Leases grew 14.85% in 2023 and then fell 14.02% in 2025.
  • A 5-year view of Current Leases shows it stood at $36.3 million in 2022, then rose by 11.18% to $40.4 million in 2023, then rose by 3.22% to $41.7 million in 2024, then decreased by 13.43% to $36.1 million in 2025, then rose by 0.28% to $36.2 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Current Leases are $36.2 million (Q1 2026), $36.1 million (Q4 2025), and $36.8 million (Q3 2025).